Status:
COMPLETED
Detection of Immunotoxic Gluten Peptides in Feces
Lead Sponsor:
University of Seville
Collaborating Sponsors:
Instituto Hispalense de Pediatría, Seville, Spain
Conditions:
Celiac Disease
Eligibility:
All Genders
1-12 years
Brief Summary
The purpose of this study is to monitor of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces.
Detailed Description
Certain immunotoxic peptides from gluten are resistant to gastrointestinal digestion and can interact with celiac patient factors to trigger immunological response. Gluten-free diet (GFD) is the only ...
Eligibility Criteria
Inclusion
- Celiac patient
- 1-12 years old
- Written informed consent
Exclusion
- Known inflammatory bowel diseases
- Participation in any other studies involving investigational concomitantly or within two weeks prior to entry into the study and during the course of the study
Key Trial Info
Start Date :
April 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT01478867
Start Date
April 1 2011
End Date
July 1 2011
Last Update
November 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Microbiology and Parasitology, Faculty of Pharmacy, University of Seville
Seville, Seville, Spain, 41012